Active	Status	Sponsor type	Region	Phase	Filter
25 Active 19 Inactive 44 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xu, Gang
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis	Suspended	2	279	Europe, US, RoW	zetomipzomib, KZR-616, placebo, matching placebo	Kezar Life Sciences, Inc.	Lupus Nephritis	05/26	07/26
Ning, Qin
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23
B-Sure, NCT04954859 / 2021-000554-26: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants	Recruiting	2	450	Europe, Canada, Japan, US, RoW	Bepirovirsen, Placebo	GlaxoSmithKline, GlaxoSmithKline Research & Development Limited	Hepatitis B	02/29	02/29
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B	Not yet recruiting	1/2	162	RoW	TQA3038 injection/placebo, Nucleotide drugs Control group	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Hepatitis B, Chronic	09/26	09/26
TRUE, NCT03752658: TAF Real World Study for Universal Effectiveness	Recruiting	N/A	500	RoW	Tenofovir Alafenamide, Vemlidy®	Tongji Hospital, Gilead Sciences	Chronic Hepatitis b	05/23	09/23
Zhang, Zhengang
No trials found